Profiling Studies in Ovarian Cancer: A Review

CME Activity Information
Release Date:	August 31, 2007
Most Recent Review:	August 31, 2007*
Most Recent Update:	August 31, 2007
Date Credit Expires:	August 31, 2009
Time to Complete:	1 hour
Medium:	Internet Online
*Click here to learn more about our review process.

Instructions for Participation

1. Read the following information before beginning the educational activity and click the "Take this course" link at the bottom of the page
2. Study the educational activity
3. Complete the CME quiz and evaluation
4. After successful completion of the CME quiz and evaluation, you will receive the credit or participation certificate

   *The CME quiz and evaluation must be completed by August 31, 2009, in order to receive the credit or participation certificate.

1. Discuss the present status of treating ovarian cancer.
2. Summarize the research in microarray gene profiling.
3. Describe the weakness in microarray gene profile research.
4. Identify the potential applications of gene profiling.

All information is submitted and reviewed and found to be scientifically rigorous, based on the best available evidence, fair and balanced, and free of commercial bias. All the recommendations involving clinical medicine in this CME activity are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection and analysis.

Any potential conflicts of interests are resolved via The Oncologist's anonymous peer review process: http://theoncologist.alphamedpress.org/misc/ifora.shtml. All manuscripts are reviewed by the Editorial Board with ad hoc assistance from two or more external experts in the field. All final publication decisions are made by the Editorial Board. The acceptance of a manuscript is based on its originality and importance to the field as assessed by the Editors.

Credentials: Departments of Gynecological Oncology, Medical Oncology, and Genetics, University Medical Center Groningen, Groningen, The Netherlands.
Disclosures: The author has indicated no relevant commercial relationships.

Credentials: Departments of Gynecological and Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Disclosures: The author has indicated no relevant commercial relationships.

Credentials: Department of Gynecological Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Disclosures: The author has indicated no relevant commercial relationships.

Credentials: Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Disclosures: The author has indicated no relevant commercial relationships.

Credentials: Department of Genetics, University Medical Center Groningen,Groningen, The Netherlands.
Disclosures: The author has indicated no relevant commercial relationships.

Credentials: Department of Medical Oncology, University Medical Center Groningen,Groningen, The Netherlands. Telephone: 31-50-361-2821/1847; Fax: 31-50-361-4862; E-mail: e.g.e.de.vries{at}int.umcg.nl.
Disclosures: The author has indicated no relevant commercial relationships.

Anne P. G. Crijns, M.D.

Credentials: Departments of Gynecological and Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Disclosures: The author has indicated no relevant commercial relationships.

• Take this course